Investment Management - Healthcare™ ::
Through the use of Revere Healthcare™, a comprehensive pipeline and regulatory information tool, investment managers can confidently pursue investment opportunities in the biopharmaceutical and medical technology industries.
The Revere Healthcare™ datafeed provides ongoing coverage on three types of events:
New Drug Application (NDA)/Biologic License Application (BLA) Filings, FDA Advisory Meetings, and Prescription Drug User Fee Act (PDUFA) Dates.
Relying on Revere’s proprietary drug database that tracks the pipeline of all US- and Canadian-listed biopharmaceutical and medical technology companies, the real-time Revere Healthcare™ datafeed offers unmatched tracking capability.
Revere Healthcare™ includes the following key information:
- Tradename and generic name of each drug candidate
- Name and ticker of the drug/device developer(s)
- Indication(s) seeking FDA approval
- Drug/candidate primary mechanism of action (PMOA)
- Revere Hierarchy™ location of the relevant drugs/device
- Directly competing drugs/devices that are either approved or in late clinical stage of development
- Complete data on filings, meetings and dates for over three years.